Sandvine, a market-leading provider of Over-the-Top Application Classification and Quality of Experience solutions, today announced that it has completed its restructuring and emerged as AppLogic Networks (the “Company”). This marks the start of a new chapter for the Company following a significant transformation over the past year, which has included enhancing its use of artificial intelligence and machine learning, shifting to software-only solutions, boosting the company’s financial strength...

Forrester (Nasdaq: FORR) today announced the full conference agenda for its CX Summit EMEA event, scheduled to take place in London and digitally on June 2–4, 2025. In today’s competitive market, customers expect consistent and personalised experiences across every interaction. To meet these expectations, leaders must focus on several key initiatives, including delivering data-driven personalisation, implementing effective measurement tools, and leveraging technology to drive meaningful engagem...

Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) today announced positive topline results for the Phase 3 VERIFY study, in which phlebotomy-dependent patients with polycythemia vera (PV) were randomized to treatment with either rusfertide or placebo, as an add-on to standard of care treatment. The study met its primary endpoint and all four key secondary endpoints. Rusfertide is a first-in-class investigational hepcidin mimetic peptide therapeutic, whi...